Clinical Outcomes Of Patients Implanted With A Monofocal Non-Constant Aberration Aspheric Intraocular Lens

The purpose of the present study was to assess the refractive and visual outcomes following cataract surgery and implantation of a new monofocal non-constant aberration aspheric intraocular lens (IOL): the CT LUCIA 621P IOL.

Oftalvist, Spain

Patients who underwent implantation the CT LUCIA 621P IOL (Carl Zeiss Meditec AG, Jena, Germany) were retrospectively analyzed in this study. This hydrophobic acrylic lens has a design with a with a C-loop platform with an optimized ZO non-constant aberration aspheric design. This single-center retrospective study from the Oftalvist center in Huelva (Spain) was approved by the Ethics Committee of the Hospital Clínico San Carlos (Madrid, Spain) and was conducted in accordance with the tenets of the Declaration of Helsinki. The study was registered at the DRKS German Clinical Trials Register (clinical registration number DRKS00028270). 

All cataract surgical procedures were performed under topical anaesthesia through a 2.2-mm temporally located clear corneal incision. The IOL was implanted using a preloaded injector through the 2.2-mm corneal incision. After centering the IOL and complete removal of the viscoelastic, the surgery ended sealing the incisions by means of hydration and administration of 1 mg of cefuroxime. Main outcome measures were refractive error and monocular corrected distance visual acuity (CDVA) and monocular uncorrected distance visual acuity (UDVA) values. Patients were evaluated at 1-month post-surgery and intra- a post-operative complications were recorded. No adverse events were reported in whole sample intra and postoperatively.

Our study shows that the CT LUCIA 621P IOL provides satisfactory visual acuity and good accuracy in the postoperative refractive error. This lens with a non-constant aberration aspheric design may be considered as a valid choice for patients in a standard-routine cataract surgery practice.